Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05866081 · ClinicalTrials.gov registry record · NA
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
A NA study of Stone, Kidney and Stone Ureter, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 792
- Enrollment target
- 16
- Study locations
NCT05866081: Recruiting NA study of Stone, Kidney and Stone Ureter, sponsored by University of Michigan.
NCT05866081 is a NA study of Stone, Kidney and Stone Ureter that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 792 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower). The trial reports 16 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05866081, a NA study of Stone, Kidney and Stone Ureter, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 792 participants
- Enrollment target
- 16
- Study locations
Study Summary
This is a multicenter prospective trial with randomized and observational cohorts assessing patient-reported outcomes and unplanned healthcare utilization following ureteroscopic treatment of renal and ureteral stones, with placement versus omission of a ureteral stent. Eligible participants in the randomization trial will be randomized to ureteroscopy with stent placement or stent omission. Eligible participants that consent to the observational only cohort will complete surveys and the treating physicians will decide the treatment options for the participants. The study team hypothesizes that: * Pain interference change from pre-surgery to Day 7-10 will differ between the two treatment arms. This hypothesis will be evaluated separately in the randomized and observational cohorts. * Unplanned healthcare utilization in the treatment arms will have different unplanned healthcare utilization ranks leading to a win proportion significantly higher or lower than 0.5 in the stent omission arm compared to the stent placement arm. This hypothesis will be evaluated separately in the randomized and observational cohorts.
Primary Outcome
This survey has 6 questions that participants select from 1(not at all) to 5 (very much) for questions 1-5 related to pain interference. For question 6 participants select from 1 (Never) to 5 (Always). There are total of 6-30 points where the higher the score the more pain interference.
Conditions Studied
Interventions
- DEVICE Standard of care stent placement
- OTHER No stent placement
- OTHER Surveys
Study Locations (16)
Michigan
- University of Michigan Health System - Ann Arbor
- University of Michigan Health System - Brighton
- Cadillac Munson Hospital - Cadillac
- St. Joseph Health System Chelsea Hospital - Chelsea
- St. Joseph Mercy Health (Trinity) - Chelsea
- Henry Ford Health System - Detroit
- Corewell Health Buttersworth Hospital - Grand Rapids
- E.W Sparrow Hospital - Lansing
- MyMichigan Medical Center Midland - Midland
- Michigan Institute of Urology Town Center Ambulatory Surgery Center - Troy
New York
- Monte Fiore - Brooklyn
- Mount Sinai - New York
Arizona
- University of Arizona - Tucson
Florida
- UF Health Shands Hospital - Gainesville
Indiana
- Indiana University Department of Urology - Indianapolis
North Carolina
- UNC Hospital - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 792 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2026-05-01 |
| Phase | NA |
What NCT05866081 shows while recruiting
NCT05866081 is an interventional study that assigns participants to a tested intervention. The registered 792 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower).
The record links to 2 conditions, with Stone, Kidney appearing as the primary indexed condition, and to 3 interventions - of which Standard of care stent placement is the first listed.
NCT05866081 lists 16 locations in 6 states (Michigan, New York, Arizona).
Frequently Asked Questions
What is clinical trial NCT05866081 about?
NCT05866081 is a clinical study titled "Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative". This is a multicenter prospective trial with randomized and observational cohorts assessing patient-reported outcomes and unplanned healthcare utilization following ureteroscopic treatment of renal and ureteral stones, with placement versus omission of a ureteral stent. Eligible participants in the...
What is the current status of trial NCT05866081?
This trial is currently recruiting. It is a NA study. The enrollment target is 792 participants. The study started on 2023-06-01. Estimated completion is 2026-05-01.
What conditions does trial NCT05866081 study?
This clinical trial studies the following conditions: Stone, Kidney, Stone Ureter.
What interventions are being tested in trial NCT05866081?
The interventions under investigation include: Standard of care stent placement (DEVICE), No stent placement (OTHER), Surveys (OTHER).
Who is sponsoring clinical trial NCT05866081?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05866081 being conducted?
This trial has 16 study locations across Arizona, Florida, Indiana, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stone, Kidney
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05866081's enrollment target sits among peer trials
792 140th of 2000 higher than 1,861 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03424005 · 792 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- NCT06722352 · 792 participants · NA
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
- NCT04967989 · 790 participants · Phase 3
Clarifying the Optimal Application of SLT Therapy Trial
- NCT06162611 · 790 participants · Phase 4
Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI